Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission.

Saved in:
Bibliographic Details
Title: Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission.
Authors: Chang XL; Vaccine & Gene Therapy Institute, Portland, OR, USA.; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA., Webb GM; Vaccine & Gene Therapy Institute, Portland, OR, USA.; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA., Wu HL; Vaccine & Gene Therapy Institute, Portland, OR, USA.; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA., Greene JM; Vaccine & Gene Therapy Institute, Portland, OR, USA., Abdulhaqq S; Vaccine & Gene Therapy Institute, Portland, OR, USA., Bateman KB; Vaccine & Gene Therapy Institute, Portland, OR, USA., Reed JS; Vaccine & Gene Therapy Institute, Portland, OR, USA., Pessoa C; Vaccine & Gene Therapy Institute, Portland, OR, USA., Weber WC; Vaccine & Gene Therapy Institute, Portland, OR, USA., Maier N; Vaccine & Gene Therapy Institute, Portland, OR, USA., Chew GM; University of Hawaii, Honolulu, HI, USA., Gilbride RM; Vaccine & Gene Therapy Institute, Portland, OR, USA., Gao L; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA., Agnor R; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA., Giobbi T; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA., Torgerson J; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA., Siess D; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA., Burnett N; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA., Fischer M; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA., Shiel O; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA., Moats C; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA., Patterson B; IncellDX, Menlo Park, CA, USA., Dhody K; Amarex Clinical Research LLC, Germantown, MD, USA., Kelly S; CytoDyn Inc., Vancouver, WA, USA., Pourhassan N; CytoDyn Inc., Vancouver, WA, USA., Magnani DM; MassBiologics of the University of Massachusetts Medical School, Boston, MA, USA., Smedley J; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA., Bimber BN; Vaccine & Gene Therapy Institute, Portland, OR, USA.; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA., Haigwood NL; Vaccine & Gene Therapy Institute, Portland, OR, USA., Hansen SG; Vaccine & Gene Therapy Institute, Portland, OR, USA., Brown TR; Palm Springs, Palm Springs, CA, USA., Ndhlovu LC; Department of Medicine, Division of Infectious Disease, Weill Cornell Medicine, New York, NY, USA. lndhlovu@med.cornell.edu., Sacha JB; Vaccine & Gene Therapy Institute, Portland, OR, USA. Sacha@ohsu.edu.; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA. Sacha@ohsu.edu.
Source: Nature communications [Nat Commun] 2021 Jun 07; Vol. 12 (1), pp. 3343. Date of Electronic Publication: 2021 Jun 07.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-021-23697-6